Loading
RG
RGT Stock: price and insider trades · Australia
RGT: what insiders have been doing
RGT, classified in the Health Care sector, is a listed company. Its insiders report their share dealings to ASX. Over the twelve months to 18 October 2026, 2 filings were filed, from 2 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (2,530 companies, median 3 filings), a count of 2 filings is below the norm.
Insider buying of RGT has been absent for the past year.
In the same sector, recent insider purchases at Cooper Companies, Inc. and Cytosorbents Corp also feature in our signals. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
as of FY 2025FY ended June 2025 · cache
A$0.03
Analyst consensus
Income statement
RevenueA$583.4k
Gross profitA$446.3k76% margin
EBITDA-A$17M-2914% margin
Net income-A$17.8M-3058.4% margin
Valuation
Beta0.41
Balance sheet & cash
Market capA$3.8M
Total debtA$8.3M
Free Cash Flow-A$9.3M
Profitability & ownership
ROA-243.0%
% insiders63.3%
% institutions0.0%
Last declaration on 5 May 2026
Declarations2 total
ShareASXASX:2924-03087063-6A1324276
●
ShareASXASX:2924-03087062-6A1324274
2 of 2 declarations
About RGT
RGT is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance healthcare.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
